Novo Nordisk is banking on its pen-filled device and insulin leadership in India to gain a strong market share despite ...

A new study suggests that popular weight loss medications could significantly benefit patients awaiting kidney transplants.

As weight loss medications like Mounjaro continue to make waves across the globe, a new concern is quietly rising alongside ...

A new study involving nearly 1.7 million patients suggests that semaglutide — a drug that mimics a gut hormone to lower blood sugar and aid weight loss — could significantly cut dementia risk in older ...

Slashing health care support for low-income Californians isn’t just a budget decision, it is a public health crisis in the ...

Novo Nordisk has terminated its partnership with telehealth company Hims & Hers Health, accusing it of deceptively marketing weight-loss drugs.

Experts say hair loss typically occurs three to four months after rapid weight loss and it's usually temporary, lasting for ...

Dr. Jeffrey Kopin, Chief Medical Officer for Northwestern Medicine Lake Forest Hospital, joins John Williams to talk about ...

GLP-1 drugs like Ozempic and Zepbound are great at promoting weight loss, but they also cause folks to lose muscle along with ...

Novo Nordisk had been providing Hims & Hers with the FDA-approved Wegovy, an injectable semaglutide used for weight loss ...

Below are a few more promising studies of weight-loss drugs. Combining bimagrumab, an investigational human monoclonal antibody that binds to and inhibits activin receptor type-2B, with semaglutide ...

Diabetes drug semaglutide linked to reduced risk of dementia in type 2 diabetes patients Effects strongest in women and older ...